Researchers have found a way to cleverly override signals that tell breast cancer cells to keep surviving in the face of anticancer treatment. The investigational agent they used renews the sensitivity of these breast cancer cells to treatment by fulvestrant which had stopped working.
Experimental drug reduces tumor resistance to breast cancer therapy
January 10th, 2010 by Newspublichealth.com
Leave a Reply
Sorry, no posts matched your criteria.